Phase 3 Breast Cancer Trial, Recruiting NCT07350928 Sponsor: Tianjin Medical University Cancer Institute and Hospital Condition: Breast Cancer
Back to Breast Cancer

Phase 3 Breast Cancer Trial, Recruiting

NCT07350928
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between the ages of 20 and 70
  • People who have been assessed by an anaesthesiologist as being in generally good to mild-risk health (classified as ASA I or II — confirm with trial site if unsure what this means)
  • People with a body mass index (BMI) between 18 and 26 kg/m²
  • People who are willing and able to sign a consent form agreeing to take part in the study

Who may not be able to join:

  • People the researchers consider unsuitable for receiving medication through a nasal spray, such as those with severe hay fever-type nasal conditions or nasal structural problems
  • People with a very slow heart rate (fewer than 50 beats per minute) or a history of heart rhythm conduction problems
  • People with a history of upper respiratory tract infections (such as infections affecting the nose, throat, or airways)
  • People with a history of asthma
  • People with a known allergy to DEX (dexmedetomidine) or local anaesthetic medicines
  • People who have taken anti-anxiety medication before the operation
  • People with a history of stroke or mini-strokes (transient ischemic attacks)
  • People whose blood pressure is not well controlled, even with medication
  • People with a history of mental illness, memory or thinking difficulties, or epilepsy
  • People with a history of pregnancy
  • People who have been regularly taking sedatives or pain relief medicines over a long period
  • People with a history of liver or kidney problems
  • People with a history of drug or alcohol misuse
  • People the trial reviewers consider unsuitable for other reasons, such as concerns about whether they would be able to follow the trial's procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +86 158 2294 6764

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Observer's Assessment of Alterness/Sedation and Numerical rating scale; Hospital Anxiety and Depression Scale (HADS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov